Summit Therapeutics (SMMT) Receivables (2017 - 2022)
Summit Therapeutics' (SMMT) quarterly Receivables came in at $349000.0 in Q4 2022, down 82.88% YoY from $2.0 million in Q4 2021, and up 149.29% on a QoQ basis from $140000.0 in Q3 2022.
Summit Therapeutics (SMMT) Receivables (2017 - 2022) Analysis & Trends
Summit Therapeutics (SMMT) has 6 years of Receivables data on file, last reported at $349000.0 in Q4 2022.
- Quarterly Receivables fell 82.88% year-over-year to $349000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $349000.0 (down 82.88% YoY) and the FY2022 annual result came in at $349000.0, down 82.88% from the prior year.
- Receivables grew to $349000.0 in Q4 2022, from $140000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $22.2 million in Q1 2019 to a low of $140000.0 in Q3 2022.
- A 5-year average of $6.5 million and a median of $2.2 million in 2021 frame the typical range for Receivables.
- Annual changes were most pronounced in 2018 — Receivables jumped 1064.86% — and 2020, when it plunged 97.15%.
- Tracing SMMT's Receivables over 5 years: stood at $19.8 million in 2018, then plunged by 41.4% to $11.6 million in 2019, then sank by 97.15% to $331000.0 in 2020, then soared by 515.71% to $2.0 million in 2021, then plunged by 82.88% to $349000.0 in 2022.
- The last three Receivables figures came in at $349000.0 (Q4 2022), $140000.0 (Q3 2022), and $1.3 million (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Summit Therapeutics | 10.59 Bn | 9.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 349,000.00 |
| Sep 30, 2022 | 140,000.00 |
| Jun 30, 2022 | 1.35 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 2.04 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Jun 30, 2021 | 1.05 Mn |
| Mar 31, 2021 | 447,000.00 |
| Dec 31, 2020 | 331,000.00 |
| Sep 30, 2020 | 4.08 Mn |
| Mar 31, 2020 | 12.54 Mn |
| Dec 31, 2019 | 11.60 Mn |
| Oct 31, 2019 | 11.08 Mn |
| Jul 31, 2019 | 13.54 Mn |
| Jan 31, 2019 | 22.15 Mn |
| Jan 31, 2018 | 19.79 Mn |
| Jan 31, 2017 | 1.70 Mn |